Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesWhat measures relieve postherpetic neuralgia?
The Journal of Family Practice, 07/02/09
Garroway N et al. - Postherpetic neuralgia (PHN) is defined as pain lasting 1 to 3 months after resolution of acute herpes zoster (shingles) rash. It occurs in approximately 10% to 15% of patients and can cause significant morbidity. Tricyclic antidepressants, gabapentin, and pregabalin effectively reduce pain (strength of recommendation: A, at least 2 good-quality randomized controlled trials [RCTs] and/or meta-analyses). Opioids have demonstrated pain relief in 3 RCTs (SOR: A, consistent RCTs). Capsaicin and the lidocaine 5% patch relieve pain and decrease allodynia (SOR: B, recommendations from meta-analyses and lower-quality RCTs).
Related Articles
Tinnitus in postherpetic neuralgia
The Journal of Headache and Pain, 10/26/09
Relevance Score: 67%
Postherpetic Neuralgia: From Preclinical Models to the Clinic
Neurotherapeutics, 10/05/09
Relevance Score: 67%
The Effectiveness of Repetitive Paravertebral Injections with Local Anesthetics and Steroids for the Prevention of Postherpetic Neuralgia in Patients with Acute Herpes Zoster
Anesthesia & Analgesia, 10/21/09
Relevance Score: 66%
Treatment of Herpes Zoster and Postherpetic Neuralgia
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 10/19/09
Relevance Score: 66%
Granulocyte colony-stimulating factor for recalcitrant postherpetic neuralgia: a prospective, open, pilot study in three patients
Clinical and Experimental Dermatology, 10/01/09
Relevance Score: 65%
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Foam sclerotherapy: cardiac and cerebral monitoring
Phlebology, 12/04/09
Lapatinib Plus Capecitabine Resolved Human Epidermal Growth Factor Receptor 2-Positive Brain Metastases
American Journal of Therapeutics, 12/04/09
Lipid profile in normal weight migraineurs – evidence for cardiovascular risk
European Journal of Neurology, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor